About: Franklin v. Parke-Davis

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Franklin v. Parke-Davis Goto Sponge NotDistinct Permalink

An Entity of Type : yago:YagoPermanentlyLocatedEntity, within Data Space : dbpedia.org associated with source document(s)
QRcode icon

http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FFranklin_v._Parke-Davis

Franklin v. Parke-Davis is a lawsuit filed in 1996 against Parke-Davis, a division of Warner-Lambert Company, and eventually against Pfizer (which bought Warner-Lambert in 2000) under the qui tam provisions of the False Claims Act. The suit was commenced by David Franklin, a microbiologist hired in the spring of 1996 in a sales capacity at Parke-Davis, a pharmaceutical subsidiary of Warner-Lambert (Warner-Lambert was subsequently acquired by Pfizer in 2000). In denying the defendants' motion for summary judgment, the court for the first time recognized off-label promotion of drugs could cause Medicaid to pay for prescriptions that were not reimbursable, triggering False Claims Act liability. The case was also significant in exposing the degree to which publication bias impacts the randomiz

Attributes	Values
rdf:type	yago:WikicatLawsuits yago:Abstraction100002137 yago:Act100030358 yago:DueProcess101181475 yago:Event100029378 yago:GroupAction101080366 yago:Lawsuit101182654 yago:Proceeding101184814 yago:PsychologicalFeature100023100 yago:YagoPermanentlyLocatedEntity
rdfs:label	Franklin v. Parke-Davis (en)
rdfs:comment	Franklin v. Parke-Davis is a lawsuit filed in 1996 against Parke-Davis, a division of Warner-Lambert Company, and eventually against Pfizer (which bought Warner-Lambert in 2000) under the qui tam provisions of the False Claims Act. The suit was commenced by David Franklin, a microbiologist hired in the spring of 1996 in a sales capacity at Parke-Davis, a pharmaceutical subsidiary of Warner-Lambert (Warner-Lambert was subsequently acquired by Pfizer in 2000). In denying the defendants' motion for summary judgment, the court for the first time recognized off-label promotion of drugs could cause Medicaid to pay for prescriptions that were not reimbursable, triggering False Claims Act liability. The case was also significant in exposing the degree to which publication bias impacts the randomiz (en)
name	Franklin v. Parke-Davis (en)
dcterms:subject	2003 in United States case law Fraud in the United States United States District Court for the District of Massachusetts cases Off-label drug use Pfizer Drug advertising
Wikipage page ID	36417415 (xsd:integer)
Wikipage revision ID	1124508632 (xsd:integer)
Link from a Wikipage to another Wikipage	2003 in United States case law Epilepsy F. Supp. 2d Bipolar disorder David Franklin (scientist) Patti B. Saris Pfizer United States Department of Justice United States District Court for the District of Massachusetts List of off-label promotion pharmaceutical settlements Fraud in the United States United States District Court for the District of Massachusetts cases Qui tam dbr:Gabapentin Off-label drug use Consumer & Prescriber Grant Program Continuing medical education Letters to the editor Parke-Davis Medicaid Microbiologist Westlaw Amarin Corporation Ethyl eicosapentaenoic acid False Claims Act Federal Food, Drug, and Cosmetic Act Food and Drug Administration Formulary (pharmacy) Kickback (bribery) Quid pro quo Pfizer Drug advertising Case report Publication bias Medical science liaison Seeding trial Summary judgment Off-label use Migraines STEPS trial Off-label marketing List of largest pharmaceutical settlements in the United States Warner-Lambert Academic literature Attention-deficit disorder Attention deficit disorder Advisory boards
Link from a Wikipage to an external page	https://www.courtlistener.com/docket/4276535/franklin-v-parke-davis/ https://www.leagle.com/decision/2001186147fsupp2d391180
sameAs	Franklin v. Parke-Davis Franklin v. Parke-Davis Franklin v. Parke-Davis Franklin v. Parke-Davis
dbp:wikiPageUsesTemplate	dbt:Main dbt:Reflist dbt:Rp dbt:Infobox_United_States_District_Court_case
docket	1 (xsd:integer)
citations	2003 (xsd:integer)
court	United States District Court for the District of Massachusetts
full name	United States of America ex rel. David Franklin v. Parke-Davis, Division of Warner-Lambert Company (en)
Holding	Off-label promotion of pharmaceutical products which causes false claims for payment under the federal Medicaid program is a valid theory of recovery under the False Claims Act. (en)
keywords	False Claims Act (en)
has abstract	Franklin v. Parke-Davis is a lawsuit filed in 1996 against Parke-Davis, a division of Warner-Lambert Company, and eventually against Pfizer (which bought Warner-Lambert in 2000) under the qui tam provisions of the False Claims Act. The suit was commenced by David Franklin, a microbiologist hired in the spring of 1996 in a sales capacity at Parke-Davis, a pharmaceutical subsidiary of Warner-Lambert (Warner-Lambert was subsequently acquired by Pfizer in 2000). In denying the defendants' motion for summary judgment, the court for the first time recognized off-label promotion of drugs could cause Medicaid to pay for prescriptions that were not reimbursable, triggering False Claims Act liability. The case was also significant in exposing the degree to which publication bias impacts the randomized controlled studies conducted by pharmaceutical companies to test the efficacy of their products. Ultimately, the parties reached a settlement agreement of $430 million to resolve all civil claims and criminal charges stemming from the qui tam complaint. At the time of the settlement in May 2004, it represented one of the largest False Claims Act recoveries against a pharmaceutical company in U.S. history, and was the first off-label promotion settlement under the False Claims Act. (en)
date decided	2003-08-22 (xsd:date)
judge	Patti B. Saris
prior actions	172800.0 (second)
prov:wasDerivedFrom	wikipedia-en:Franklin_v._Parke-Davis?oldid=1124508632&ns=0
page length (characters) of wiki page	15358 (xsd:nonNegativeInteger)
foaf:isPrimaryTopicOf	wikipedia-en:Franklin_v._Parke-Davis
is Link from a Wikipage to another Wikipage of	David Franklin (scientist) List of largest civil only pharmaceutical settlements List of largest pharmaceutical settlements List of off-label promotion pharmaceutical settlements Qui tam dbr:Gabapentin Consumer & Prescriber Grant Program Parke-Davis Marketing of off-label use

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 54 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software